Physician

Adam James Crowson, PA-C

According to 2025 Medicare claims, Adam Crowson, PA-C (NPI: 1225635329) practices physician assistant in the Crestview-Fort Walton Beach-Destin, FL market, with the plurality of this provider's patient population coming from Okaloosa, FL. This provider's primary affiliated billing organization is MAIN STREET MEDICAL CENTER OF CRESTVIEW, PA (NPI: 1619181914; TIN: 208417522) and primary practice location at 32536-3541.

Crowson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 105 traditional Medicare patients, billed 190 HCPCS/CPT codes, and received $9,902 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,945 prescription claims across 411 beneficiaries totaling $696,562 in drug costs, led by Mounjaro (Tirzepatide). 2023 DME data shows 35 claims. Open Payments data shows 97 records totaling $1,270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,046 to $9,902. Similarly, Part D prescription costs have moved sharply higher in recent years, from $658 to $696,562. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	39	86	$4,046
2021	57	146	$3,686
2022	18	21	$2,427
2023	12	12	$1,241
2024	105	190	$9,902

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	51	69	$658
2021	148	318	$25,608
2022	103	920	$137,862
2023	366	3,220	$454,179
2024	411	4,945	$696,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$2,022
2023	N/R	35	$7,065
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	46	50	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	36	38	$60
99442	Telephone medical discussion with physician, 11-20 minutes	12	12	$58
83036	Hemoglobin a1c level	13	14	$10
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	21	22	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	114	3,870	$145,719
Ozempic	Semaglutide	81	2,835	$89,957
Eliquis	Apixaban	85	4,305	$81,159
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	2,730	$58,226
Jardiance	Empagliflozin	43	2,610	$52,197

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$1,270	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam James Crowson, PA-C?

Tedicare shows public-source Medicare data for Adam James Crowson, PA-C (NPI 1225635329), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam James Crowson, PA-C have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam James Crowson, PA-C?

Adam James Crowson, PA-C is linked to MAIN STREET MEDICAL CENTER OF CRESTVIEW, PA (billing NPI 1619181914) in the available physician profile data.

Does Adam James Crowson, PA-C have Open Payments data?

Adam James Crowson, PA-C has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.